Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
acute, animal, ascending, cap, chloride, concrete, curated, dose, EEG, electroencephalogram, extrinsic, gel, half, hard, hyperexcitability, hyperexcitabilty, intractable, intrinsic, Israel, joining, kinase, Ligand, magnetic, marker, modulating, neuronal, pharmacodynamic, potassium, protein, refractory, replicable, resonance, spectroscopy, stimulation, transcranial, unique
Removed:
accrue, alter, assign, biology, Biosafety, cell, cleared, Committee, controlled, DNA, efficient, epilepsy, expired, exploitation, extensively, gene, host, insight, jointly, led, molecular, negligible, persistent, receipt, retroviral, settlement, stricter, tangible, title, transferring, unfavorable, unpredictability, unsafe
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view